Stock Events

HLB Panagene. 

₩3,740
2
+₩0+0% Today

Statistics

Day High
3,890
Day Low
3,705
52W High
5,650
52W Low
2,800
Volume
252,945
Avg. Volume
1,059,426
Mkt Cap
158.93B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31DecConfirmed
Q1 2017
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-139.83
-95.45
-51.07
-6.7
Expected EPS
N/A
Actual EPS
-62.9143

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 046210.KQ. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Panagene Inc. develops products in the field of molecular diagnostics in South Korea. Its products include Liquid biopsy products for lung and colon cancers; tissue biopsy products for lung, thyroid, pancreatic, and colon cancers, as well as glioblastoma, myeloproliferative neoplasm, chronic myelogenous leukemia, central nervous system, myelofibrosis, and polycythemia vera diseases. The company also offers products for cervical cancer, sexually transmitted, and extreme drug resistance diseases; and peptide nucleic acid products. The company was formerly known as Koram Panagene Ltd. and changed its name to Panagene Inc. in January 2009. Panagene Inc. was incorporated in 1976 and is based in Daejeon, South Korea.
Show more...
CEO
Byung-Hoon Lee
Employees
63
Country
KR
ISIN
KR7046210001

Listings